The last 10 to 15 years has seen important advances in the management of advanced renal-cell cancer. Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss how real-world efficacy and safety data influence the conversations they have with their patients with advanced renal-cell carcinoma regarding treatment options.
Baylor Charles A. Sammons Cancer Center
Dallas, TX
Dallas, TX
Beth Israel Deaconess Medical Center
Boston, MA
Boston, MA
Cleveland Clinic Taussig Cancer Center
Cleveland, OH
Cleveland, OH
Related Items
Videos published on December 19, 2023 in Interview with the Innovators
Videos published on December 18, 2023 in Interview with the Innovators